IMIDomics Inc. Email Format

Biotechnology ResearchCalifornia, United States11-50 Employees

IMIDomics Inc. is a biotechnology company focused on patient-centric drug discovery for immune-mediated inflammatory diseases (IMIDs). It aims to identify responsive patient populations and uncover novel therapeutic targets by integrating clinical, epidemiological, and patient-derived biomolecular data through its Clinical Discovery Engine, developed in collaboration with the Vall d’Hebron Institute of Research. This approach seeks to improve the probability of successful IMID drug discovery and development by leveraging well-defined patient samples and clinically relevant data.
Based in San Rafael, California, IMIDomics operates within the biotechnology research sector and collaborates with academic and industry partners to advance treatments for a range of IMIDs, including conditions such as ulcerative colitis, Crohn’s disease, psoriatic arthritis, rheumatoid arthritis, psoriasis, and systemic lupus erythematosus. The company has pursued partnerships and strategic engagements with organizations and institutions to expand its data resources and translate research findings into development programs, as evidenced by recent board appointments and collaborations.

Sign up for free to view info

Company overview Employee directory